| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.008 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.009 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |